Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Italy

European Research Council grant · Running

HySENSE Advanced Sensing Platforms for Single-Cell Metabolic Flux Analysis in Heterogeneous Cell Systems

Coordinator
Consiglio Nazionale Delle Ricerche, Italy
Runs
1 September 2025 to 28 February 2027
Status
Running
EU funding
€150k
Total cost
—
Partners
2 organisations in 1 countries
Type
European Research Council grant
Grant agreement
101212914

What the project is doing

In the project's own words, from its summary on CORDIS.

Accurately assessing hypoxia and acidosis in the tumor microenvironment is crucial for understanding tumor behavior and determining treatments effectiveness. These conditions, caused by uncontrolled cancer cell proliferation, are key indicators of aggressiveness and metastasis risk, yet remain difficult to measure precisely. The HySENSE project addresses this gap with an innovative sensor kit capable of real-time, cell-specific measurements of oxygen and pH at high spatio-temporal resolution.

This advanced technology surpasses current tools, offering deeper insights into tumor behavior and therapeutic effects. HySENSE will be validated using patient-derived colorectal cancer models, and a business feasibility study will define the path to commercialization. By enabling precise analysis of hypoxia and acidosis, HySENSE aims to transform cancer diagnostics and treatment planning, ultimately improving patient care.

Topics

Who is involved

OrganisationCityCountryRole
Consiglio Nazionale Delle RicercheRomaItalyCoordinator
Day One Societa a Responsabilita LimitataRoma RmItalyParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI